Outperform - Price 10.42 on March 4 by Raymond James [Marine-driller] CalDive had normalized 4Q earnings per share of 28 cents [versus] our 25 cents/the Street's 30 cents. Acquisition of Horizon [looks like] a great long-term decision. International revenue is expanding to 35%.…[The shares] remain attractive at 8.7 times our new '08 EPS estimate and roughly five times [earnings before interest, taxes, depreciation and amortization]…we've reduced our '08 EPS estimate to $1.20 from $1.25, and initiate $1.40 EEPS for '09.…Target: 15. Market-cap: $923 million.

Buy - Price 37.86 on March 4 by Hilliard Lyons We're introducing an '09 EPS estimate of $1.96. We believe the valuation is appealing, with CWT trading at a discount to its peer group at 21.8 times our '08 EPS estimate and 19.3 times our '09 EPS estimate, versus 21.9 times and 20.7 times '07 and '08 estimates for the water-utilities index, respectively. Our 44 target us[es] a multiple of 25 times our '08 EPS estimate of $1.74 [based on] growth prospects and historical trading range. Market-cap: $783 million.

Hold - Price 37.78 on March 6 by Wedbush Morgan A review of United Technologies' three most prominent unsolicited acquisitions suggests DBD shareholders can expect the acquisition to be complete for $42 within the next 60 days. We believe the key for Diebold [whose products include automatic-teller machines] to get a better outcome will be to bring in additional bidders. [Diebold's] net debt is $326.2 million. Target: 40. Market-cap: $2.6 billion.

Outperform - Price 20.01 on March 4 by Cowen & Co. Despite our 5-cent and 1-cent reduction to FY08 and FY09 EPS estimates, on unfavorable NAND-pricing conditions, valuation still looks attractive. INTC currently trades at 7.8 times [enterprise value]/Ebit '09E, at the trough of its historical valuation. Market-cap $119.8 billion.

Buy - Price 2.36 on March 4 by Singular Research A burgeoning Medicare-eligible population provides a positive demand driver for Medicare Advantage providers [like MDF]…Sum-of-the-parts analysis shows MDF worth at least 3.50…Balance-sheet cash/stable cash flows from the [provider service network show] significant downside protection for MDF. Market-cap: $122 million.

Neutral - Price 44.24 on March 4 by Jesup & Lamont [Geothermal and energy-recovery firm] ORA's 4Q was below guidance, Street consensus/our estimates. The disappointment led to full-year numbers essentially below estimates, proportional to the Q4 miss. We believe Ormat's premium valuation, due to vertically integrated positioning, will continue. At 28 times our 2009 new EPS estimate of $1.58, [we are positive long-term, but will remain] Neutral...awaiting a better entry point. Market-cap: $1.81 billion.

Market Outperform - Price 10.46 on March 4 by JMP Securities PCAP had net interest income of $6.5 million, nearly $1 million higher than our estimate and up 18% from 3Q07, [with] balance-sheet growth of 18%, well ahead of our 4% estimate and contributing to better-than-expected net interest income. Our rating is based on an attractive 12% dividend yield. Target: 14. Market-cap: $195 million.

Underperform - Price 12.73 on March 4 by Fox-Pitt Kelton Cochran Caronia Waller Lowering to Underperform on credit/capital concerns...PBKS disclosed it could...write off $47.5 million…a 100% write-off could reduce tangible capital by 50…basis points.